1.

Change of initial oral antidiabetic therapy in type 2 diabetic patients

1.

Yield of opportunistic targeted screening for type 2 diabetes in primary care: The Diabscreen study

1.

The clinical value of metabolic syndrome and risks of cardiometabolic events and mortality in the elderly: The Rotterdam study

1.

Novel inflammatory markers for incident pre-diabetes and type 2 diabetes: the Rotterdam Study